Video Buzz v1
Highlighting streaming videos you should be watching
RelatedLinks
June 23rd
June 22nd
June 19th
- 'Surprise' prostate result probed: Researchers are probing an unexpected success in a study of an experimental treatment for prostate cancer. In three men with advanced disease, use of an immune drug called ipilimumab, shrank their tumours to such an extent surgeons were able to operate.
June 16th
June 5th
May 6th
April 28th
April 24th
- Metro: Antibody therapy kills cancer cells': Cancer Research UK-funded scientists have discovered that linking a molecule which initiates antibody production
April 16th
- The Immune System - National Cancer Institute: Understanding Cancer Series: The Immune System
April 14th
April 13th
- CANCER VACCINES AND IMMUNOTHERAPY - lefeurope.com: Cancer immunotherapie s, including cancer vaccines, are novel investigationa l cancer therapies. In contrast to chemotherapy and radiotherapy regimens that are often associated with severe side effects, cancer immunotherapy stimulates the body?s immune system and natural resistance to cancer, thus offering a gentler means of cancer treatment that is less damaging to the rest of the body. Surgery is generally (but not always) performed, prior to immunotherapy, to remove most of the tumor (Hanna MG, Jr. et al 2001
April 10th
- Patients 'free from cancer' after immune-boost treatment - Telegraph
- Human papillomavirus therapeutic vaccines in head and neck tumors. - Expert Reviews - Expert Review of Anticancer Therapy - 7(5):753 - Summary: Human papillomavirus therapeutic vaccines in head and neck tumors.\nBadar acco G, Venuti A.\nExpert Rev Anticancer Ther. 2007 May
- Duke University research proposes cure for peanut allergies | The Daily Illini
April 8th
Video Buzz > Immunotherapy
No Matching Video
No video for Immunotherapy is available at this time.
Related Immunotherapy News
Johnson & Johnson Buys Access to Alzheimer?s Drug - New York Times
Johnson & Johnson will acquire ?substantially all of the assets and rights of Elan related to its Alzheimer?s immunotherapy program? through a new company, the two drug makers said in a statement. In return, Johnson & Johnson will invest $1 ...
JnJ to Initially Spend $1.5B for Elan?s Alzheimer?s Immunotherapy ... - Genetic Engineering News
Johnson & Johnson is acquiring substantially all Elan?s assets and rights related to the Alzheimer's immunotherapy program (AIP program) through a newly formed company. JnJ will invest $1 billion in Elan in exchange for newly issued American ...
Johnson & Johnson and Elan Corporation plc Announce Definitive ... - WebWire
First-in-Class Alzheimer?s Treatments Expand Existing J&J Neuroscience Pipeline Johnson & Johnson Equity Investment Provides Financial Flexibility for Elan New Brunswick, N.J., and Dublin, Ireland ? Johnson & Johnson ( NYSE: JNJ ) and Elan ...
Johnson & Johnson and Elan Corporation plc Announce Definitive ... - Phramalive.com
First-in-Class Alzheimer's Treatments Expand Existing J&J Neuroscience Pipeline Johnson & Johnson Equity Investment Provides Financial Flexibility for Elan NEW BRUNSWICK, N.J. and DUBLIN, July 2 /PRNewswire-FirstCall/ -- Johnson & Johnson ( NYSE:JNJ ...
Johnson & Johnson to acquire assets and rights related to Alzheimer's ... - TradingMarkets.com
In consideration, Elan would receive a 49.9% equity interest in the newly formed J&J company that would acquire the AIP Program. Elan would be entitled to a 49.9% share of the profits and certain royalty payments upon the commercialization of ...
Immunotherapy Podcasts
Do you prefer to listen to your immunotherapy gossip? Check out Podzy Podcast Directory > Immunotherapy.
Immunotherapy Products
Looking for immunotherapy related products, then look no further. Try our new Immunotherapy Shop.